Inovio Pharmaceuticals Hit with Securities Fraud Lawsuit Over Device Claims
Inovio Pharmaceuticals faces class action securities fraud lawsuit alleging false statements about manufacturing capabilities and regulatory timelines. Investors have until April 7, 2026 to join.
INOsecurities fraudclass action lawsuit